Matsudo, Japan, July 5, 2011- Precision System Science, Co., Ltd (PSS) announced today that PSS and Hai Kang Life Corporation Limited (HKLife, a Hong Kong based biotechnology company) reached an agreement for the co-development of genetic diagnostic instrument. Under the agreement, PSS will develop compact genetic analyzer named “Bio Reader”, in collaboration with HKLife’s team of scientists for its EFADchip®, the HKLife’s originally developed patented technology.
The Bio Reader/ EFADchip® system is expected to be marketed toward medical facilities ranged from large hospitals to small clinics all over the world for disease diagnosis, particularly infectious diseases. HKLife has become the first Asian company (excluding Japan) for PSS to come to a development agreement.
PSS believes that the agreement with the HKLife proved credibility of PSS instrumentation technologies not only in Europe and United states but in Asia, where the molecular diagnosis market is rapidly growing. PSS will further develop automated instruments in various areas to expand use of genetic analysis and in vitro diagnostics.
About Hai Kang Life Corporation Limited:
Hai Kang Life Corporation Limited was established with independent research funding in 1999. The company is strategically positioned at the hub of Asian biotechnology, equipped with the most advanced research and production facilities in both Beijing and Hong Kong. Strong working relationships with academic institutions, government and industry partners have created a solid foundation for business success. The world-class team of scientists, engineers and technologists, supported by a highly esteemed Scientific Advisory Board, is committed to maintaining Hai Kang Life’s position at the forefront of bio-business, leveraging best practices from both East and West. EFADchip® was featured in recent Science magazine issued on June 24, 2011.